An Emerging Role of RNA-Binding Proteins as Multifunctional Regulators of Lymphocyte Development and Function

Advances in Immunology

Volumn 115, Issue , 2012, Pages 161-185

  Turner, Martin ^a   Hodson, Daniel J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

AU rich element; Gene expression; HuR; Lymphocyte development; RNA stability; RNA binding protein

Indexed keywords

CD28 ANTIGEN; CELF1 PROTEIN; CYTOKINE RECEPTOR; GAMMA INTERFERON; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; POLYPYRIMIDINE TRACT BINDING PROTEIN; RNA BINDING PROTEIN; ROQUIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE INTRACELLULAR ANTIGEN 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRISTETRAPROLIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEVELOPMENT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; RNA SPLICING; RNA TRANSLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84861128352     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394299-9.00006-0     Document Type: Chapter

References (141)

1. Abdelmohsen K., Pullmann R., Lal A., Kim H.H., Galban S., Yang X., Blethrow J.D., Walker M., Shubert J., Gillespie D.A., Furneaux H., Gorospe M. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 2007, 25:543.
2. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 2010, 10:24.
3. Anderson P., Kedersha N. RNA granules: Post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 2009, 10:430.
4. Atasoy U., Watson J., Patel D., Keene J.D. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell Sci. 1998, 111(Pt 21):3145.
5. Athanasopoulos V., Barker A., Yu D., Tan A.H., Srivastava M., Contreras N., Wang J., Lam K.P., Brown S.H., Goodnow C.C., Dixon N.E., Leedman P.J., et al. The ROQUIN family of proteins localizes to stress granules via the ROQ domain and binds target mRNAs. FEBS J. 2010, 277:2109.
6. Baier G. PKC isotype functions in T lymphocytes. Ernst Schering Found. Symp. Proc. 2007, 29.
7. Bakheet T., Williams B.R., Khabar K.S. ARED 3.0: The large and diverse AU-rich transcriptome. Nucleic Acids Res. 2006, 34:D111.
8. Baou M., Jewell A., Muthurania A., Wickremasinghe R.G., Yong K.L., Carr R., Marsh P., Murphy J.J. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia 2009, 23:986.
9. Barenco M., Brewer D., Papouli E., Tomescu D., Callard R., Stark J., Hubank M. Dissection of a complex transcriptional response using genome-wide transcriptional modelling. Mol. Syst. Biol. 2009, 5:327.
10. Basu U., Meng F.L., Keim C., Grinstein V., Pefanis E., Eccleston J., Zhang T., Myers D., Wasserman C.R., Wesemann D.R., Januszyk K., Gregory R.I., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011, 144:353.
11. Beisang D., Rattenbacher B., Vlasova-St Louis I.A., Bohjanen P.R. Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation. J. Biol. Chem. 2012, 287:950.
12. Bell S.E., Sanchez M.J., Spasic-Boskovic O., Santalucia T., Gambardella L., Burton G.J., Murphy J.J., Norton J.D., Clark A.R., Turner M. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev. Dyn. 2006, 235:3144.
13. Ben-Asouli Y., Banai Y., Pel-Or Y., Shir A., Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 2002, 108:221.
14. Benjamin D., Schmidlin M., Min L., Gross B., Moroni C. BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol. Cell. Biol. 2006, 26:9497.
15. Bertossi A., Aichinger M., Sansonetti P., Lech M., Neff F., Pal M., Wunderlich F.T., Anders H.J., Klein L., Schmidt-Supprian M. Loss of Roquin induces early death and immune deregulation but not autoimmunity. J. Exp. Med. 2011, 208:1749.
16. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111.
17. Bredemeyer A.L., Helmink B.A., Innes C.L., Calderon B., McGinnis L.M., Mahowald G.K., Gapud E.J., Walker L.M., Collins J.B., Weaver B.K., Mandik-Nayak L., Schreiber R.D., et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 2008, 456:819.
18. Brewer B.Y., Malicka J., Blackshear P.J., Wilson G.M. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: Conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs. J. Biol. Chem. 2004, 279:27870.
19. Casolaro V., Fang X., Tancowny B., Fan J., Wu F., Srikantan S., Asaki S.Y., De Fanis U., Huang S.K., Gorospe M., Atasoy U.X., Stellato C. Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR. J. Allergy Clin. Immunol. 2008, 121:853.
20. Castle J.C., Zhang C., Shah J.K., Kulkarni A.V., Kalsotra A., Cooper T.A., Johnson J.M. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat. Genet. 2008, 40:1416.
21. Chamboredon S., Ciais D., Desroches-Castan A., Savi P., Bono F., Feige J.J., Cherradi N. Hypoxia-inducible factor-1alpha mRNA: A new target for destabilization by tristetraprolin in endothelial cells. Mol. Biol. Cell 2011, 22:3366.
22. Cheadle C., Fan J., Cho-Chung Y.S., Werner T., Ray J., Do L., Gorospe M., Becker K.G. Control of gene expression during T cell activation: Alternate regulation of mRNA transcription and mRNA stability. BMC Genomics 2005, 6:75.
23. Chen C.Y., Del Gatto-Konczak F., Wu Z., Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998, 280:1945.
24. Chen C.Y., Gherzi R., Andersen J.S., Gaietta G., Jurchott K., Royer H.D., Mann M., Karin M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 2000, 14:1236.
25. Chen C.Y., Gherzi R., Ong S.E., Chan E.L., Raijmakers R., Pruijn G.J., Stoecklin G., Moroni C., Mann M., Karin M. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001, 107:451.
26. Clement S.L., Scheckel C., Stoecklin G., Lykke-Andersen J. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol. Cell. Biol. 2011, 31:256.
27. Conticello S.G., Ganesh K., Xue K., Lu M., Rada C., Neuberger M.S. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol. Cell 2008, 31:474.
28. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., Xiao B., Worley P.F., Powell J.D. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011, 12:295.
29. Dolken L., Ruzsics Z., Radle B., Friedel C.C., Zimmer R., Mages J., Hoffmann R., Dickinson P., Forster T., Ghazal P., Koszinowski U.H. High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 2008, 14:1959.
30. Doller A., Pfeilschifter J., Eberhardt W. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal. 2008, 20:2165.
31. Doller A., Schlepckow K., Schwalbe H., Pfeilschifter J., Eberhardt W. Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR. Mol. Cell. Biol. 2010, 30:1397.
32. Elkon R., Zlotorynski E., Zeller K.I., Agami R. Major role for mRNA stability in shaping the kinetics of gene induction. BMC Genomics 2010, 11:259.
33. Esnault S., Shen Z.J., Whitesel E., Malter J.S. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J. Immunol. 2006, 177:6999.
34. Frasca D., Landin A.M., Alvarez J.P., Blackshear P.J., Riley R.L., Blomberg B.B. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J. Immunol. 2007, 179:918.
35. Galante P.A., Sandhu D., de Sousa Abreu R., Gradassi M., Slager N., Vogel C., de Souza S.J., Penalva L.O. A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA Biol. 2009, 6:426.
36. Gareau C., Fournier M.J., Filion C., Coudert L., Martel D., Labelle Y., Mazroui R. p21(WAF1/CIP1) upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis. PLoS One 2011, 6:e20254.
37. Ghosh M., Aguila H.L., Michaud J., Ai Y., Wu M.T., Hemmes A., Ristimaki A., Guo C., Furneaux H., Hla T. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J. Clin. Invest. 2009, 119:3530.
38. Glasmacher E., Hoefig K.P., Vogel K.U., Rath N., Du L., Wolf C., Kremmer E., Wang X., Heissmeyer V. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat. Immunol. 2010, 11:725.
39. Graham J.R., Hendershott M.C., Terragni J., Cooper G.M. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Mol. Cell. Biol. 2010, 30:5295.
40. Grigoryev Y.A., Kurian S.M., Nakorchevskiy A.A., Burke J.P., Campbell D., Head S.R., Deng J., Kantor A.B., Yates J.R., Salomon D.R. Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes. PLoS One 2009, 4:e7906.
41. Gruber A.R., Fallmann J., Kratochvill F., Kovarik P., Hofacker I.L. AREsite: A database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res. 2011, 39:D66.
42. Haks M.C., Krimpenfort P., van den Brakel J.H., Kruisbeek A.M. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 1999, 11:91.
43. Halees A.S., Hitti E., Al-Saif M., Mahmoud L., Vlasova-St Louis I.A., Beisang D.J., Bohjanen P.R., Khabar K. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol. 2011, 8:681.
44. Hamilton B.J., Genin A., Cron R.Q., Rigby W.F. Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol. Cell. Biol. 2003, 23:510.
45. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 2009, 10:281.
46. Higashi A.Y., Ikawa T., Muramatsu M., Economides A.N., Niwa A., Okuda T., Murphy A.J., Rojas J., Heike T., Nakahata T., Kawamoto H., Kita T., et al. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J. Immunol. 2009, 182:5633.
47. Hodson D.J., Janas M.L., Galloway A., Bell S.E., Andrews S., Li C.M., Pannell R., Siebel C.W., MacDonald H.R., De Keersmaecker K., Ferrando A.A., Grutz G., et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat. Immunol. 2010, 11:717.
48. Hudson B.P., Martinez-Yamout M.A., Dyson H.J., Wright P.E. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat. Struct. Mol. Biol. 2004, 11:257.
49. Iakova P., Wang G.L., Timchenko L., Michalak M., Pereira-Smith O.M., Smith J.R., Timchenko N.A. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 2004, 23:406.
50. Janas M.L., Turner M. Stromal cell-derived factor 1alpha and CXCR4: Newly defined requirements for efficient thymic beta-selection. Trends Immunol. 2010, 31:370.
51. Jiang D., Lenardo M.J., Zuniga-Pflucker J.C. p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 1996, 183:1923.
52. Kanehiro Y., Todo K., Negishi M., Fukuoka J., Gan W., Hikasa T., Kaga Y., Takemoto M., Magari M., Li X., Manley J.L., Ohmori H., et al. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1. Proc. Natl. Acad. Sci. USA 1998, 119(4):1216-1221.
53. Katsanou V., Milatos S., Yiakouvaki A., Sgantzis N., Kotsoni A., Alexiou M., Harokopos V., Aidinis V., Hemberger M., Kontoyiannis D.L. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol. Cell. Biol. 2009, 29:2762.
54. Kedar V.P., Zucconi B.E., Wilson G.M., Blackshear P.J. Direct binding of specific AUF1 isoforms to the tandem zinc finger domains of tristetraprolin (TTP) family proteins. J. Biol. Chem. 1998, 287(8):5459-5471.
55. Keene J.D. RNA regulons: Coordination of post-transcriptional events. Nat. Rev. Genet. 2007, 8:533.
56. Khabar K.S. Post-transcriptional control during chronic inflammation and cancer: A focus on AU-rich elements. Cell. Mol. Life Sci. 2010, 67:2937.
57. Kim H.H., Abdelmohsen K., Lal A., Pullmann R., Yang X., Galban S., Srikantan S., Martindale J.L., Blethrow J., Shokat K.M., Gorospe M. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 2008, 22:1804.
58. Kim H.H., Kuwano Y., Srikantan S., Lee E.K., Martindale J.L., Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009, 23:1743.
59. Kim H.H., Abdelmohsen K., Gorospe M. Regulation of HuR by DNA damage response kinases. J. Nucleic Acids 2011, 25;2010. pii: 981487.
60. Kishore S., Luber S., Zavolan M. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression. Brief. Funct. Genomics 2010, 9:391.
61. Kishore S., Jaskiewicz L., Burger L., Hausser J., Khorshid M., Zavolan M. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 2011, 8:559.
62. Kosinski P.A., Laughlin J., Singh K., Covey L.R. A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J. Immunol. 2003, 170:979.
63. Kress C., Gautier-Courteille C., Osborne H.B., Babinet C., Paillard L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol. Cell. Biol. 2007, 27:1146.
64. Lafarga V., Cuadrado A., Lopez de Silanes I., Bengoechea R., Fernandez-Capetillo O., Nebreda A.R. p38 mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell. Biol. 2009, 29:4341.
65. Lam L.T., Pickeral O.K., Peng A.C., Rosenwald A., Hurt E.M., Giltnane J.M., Averett L.M., Zhao H., Davis R.E., Sathyamoorthy M., Wahl L.M., Harris E.D., et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2001, 2(10). RESEARCH0041.
66. Lebedeva S., Jens M., Theil K., Schwanhausser B., Selbach M., Landthaler M., Rajewsky N. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 2011, 43:340.
67. Lee H.H., Yoon N.A., Vo M.T., Kim C.W., Woo J.M., Cha H.J., Cho Y.W., Lee B.J., Cho W.J., Park J.W. Tristetraprolin down-regulates IL-17 through mRNA destabilization. FEBS Lett. 2012, 586:41.
68. Liang J., Lei T., Song Y., Yanes N., Qi Y., Fu M. RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling. J. Biol. Chem. 2009, 284:29383.
69. Lin W.J., Duffy A., Chen C.Y. Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits. J. Biol. Chem. 2007, 282:19958.
70. Lindstein T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989, 244:339.
71. Linterman M.A., Rigby R.J., Wong R., Silva D., Withers D., Anderson G., Verma N.K., Brink R., Hutloff A., Goodnow C.C., Vinuesa C.G. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity 2009, 30:228.
72. Liu L., Rao J.N., Zou T., Xiao L., Wang P.Y., Turner D.J., Gorospe M., Wang J.Y. Polyamines regulate c-Myc translation through Chk2-dependent HuR phosphorylation. Mol. Biol. Cell 2009, 20:4885.
73. Long J.C., Caceres J.F. The SR protein family of splicing factors: Master regulators of gene expression. Biochem. J. 2009, 417:15.
74. Lopez de Silanes I., Zhan M., Lal A., Yang X., Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc. Natl. Acad. Sci. USA 2004, 101:2987.
75. Lu J.Y., Bergman N., Sadri N., Schneider R.J. Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA 2006, 12:883.
76. Lykke-Andersen J., Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 2005, 19:351.
77. Maitra S., Chou C.F., Luber C.A., Lee K.Y., Mann M., Chen C.Y. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA 2008, 14:950.
78. Marcais A., Tomkowiak M., Walzer T., Coupet C.A., Ravel-Chapuis A., Marvel J. Maintenance of CCL5 mRNA stores by post-effector and memory CD8 T cells is dependent on transcription and is coupled to increased mRNA stability. Eur. J. Immunol. 2006, 36:2745.
79. Marchese F.P., Aubareda A., Tudor C., Saklatvala J., Clark A.R., Dean J.L. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J. Biol. Chem. 2010, 285:27590.
80. Masuda K., Abdelmohsen K., Kim M.M., Srikantan S., Lee E.K., Tominaga K., Selimyan R., Martindale J.L., Yang X., Lehrmann E., Zhang Y., Becker K.G., et al. Global dissociation of HuR-mRNA complexes promotes cell survival after ionizing radiation. EMBO J. 2011, 30:1040.
81. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160.
82. Mazan-Mamczarz K., Hagner P.R., Zhang Y., Dai B., Lehrmann E., Becker K.G., Keene J.D., Gorospe M., Liu Z., Gartenhaus R.B. ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. Blood 2011, 117:2441.
83. Meisner N.C., Hintersteiner M., Mueller K., Bauer R., Seifert J.M., Naegeli H.U., Ottl J., Oberer L., Guenat C., Moss S., Harrer N., Woisetschlaeger M., et al. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat. Chem. Biol. 2007, 3:508.
84. Meisner N.C., Hintersteiner M., Seifert J.M., Bauer R., Benoit R.M., Widmer A., Schindler T., Uhl V., Lang M., Gstach H., Auer M. Terminal adenosyl transferase activity of posttranscriptional regulator HuR revealed by confocal on-bead screening. J. Mol. Biol. 2009, 386:435.
85. Moulton V.R., Kyttaris V.C., Juang Y.T., Chowdhury B., Tsokos G.C. The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex. J. Biol. Chem. 2008, 283:20037.
86. Mukherjee N., Lager P.J., Friedersdorf M.B., Thompson M.A., Keene J.D. Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol. Syst. Biol. 2009, 5:288.
87. Mukherjee N., Corcoran D.L., Nusbaum J.D., Reid D.W., Georgiev S., Hafner M., Ascano M., Tuschl T., Ohler U., Keene J.D. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 2011, 43:327.
88. Ning Z.Q., Norton J.D., Li J., Murphy J.J. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: Role for inhibition of an early response gene, Berg36. Eur. J. Immunol. 1996, 26:2356.
89. Nowak U., Matthews A.J., Zheng S., Chaudhuri J. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat. Immunol. 2011, 12:160.
90. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 2005, 174:953.
91. Ogilvie R.L., Sternjohn J.R., Rattenbacher B., Vlasova I.A., Williams D.A., Hau H.H., Blackshear P.J., Bohjanen P.R. Tristetraprolin mediates interferon-gamma mRNA decay. J. Biol. Chem. 2009, 284:11216.
92. Okkenhaug K., Fruman D.A. PI3Ks in lymphocyte signaling and development. Curr. Top. Microbiol. Immunol. 2010, 346:57.
93. Pan Q., Shai O., Lee L.J., Frey B.J., Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40:1413.
94. Papadaki O., Milatos S., Grammenoudi S., Mukherjee N., Keene J.D., Kontoyiannis D.L. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J. Immunol. 2009, 182:6779.
95. Pedraza-Alva G., Koulnis M., Charland C., Thornton T., Clements J.L., Schlissel M.S., Rincon M. Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J. 2006, 25:763.
96. Porter J.F., Vavassori S., Covey L.R. A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells. J. Immunol. 2008, 181:3336.
97. Qi M.Y., Wang Z.Z., Zhang Z., Shao Q., Zeng A., Li X.Q., Li W.Q., Wang C., Tian F.J., Li Q., Zou J., Qin Y.W., et al. AU-rich element-dependent translation repression requires the cooperation of tristetraprolin and RCK/P54. Mol. Cell. Biol. 1998, 32(5):913-928.
98. Rabani M., Levin J.Z., Fan L., Adiconis X., Raychowdhury R., Garber M., Gnirke A., Nusbaum C., Hacohen N., Friedman N., Amit I., Regev A. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat. Biotechnol. 2011, 29:436.
99. Radtke F., Fasnacht N., Macdonald H.R. Notch signaling in the immune system. Immunity 2010, 32:14.
100. Raghavan A., Robison R.L., McNabb J., Miller C.R., Williams D.A., Bohjanen P.R. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 2001, 276:47958.
101. Ramgolam V.S., DeGregorio S.D., Rao G.K., Collinge M., Subaran S.S., Markovic-Plese S., Pardi R., Bender J.R. T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade. PLoS One 2010, 5:e14450.
102. Reinhardt H.C., Hasskamp P., Schmedding I., Morandell S., van Vugt M.A., Wang X., Linding R., Ong S.E., Weaver D., Carr S.A., Yaffe M.B. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol. Cell 2010, 40:34.
103. Sadri N., Lu J.Y., Badura M.L., Schneider R.J. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010, 11:1.
104. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643.
105. Sandler H., Stoecklin G. Control of mRNA decay by phosphorylation of tristetraprolin. Biochem. Soc. Trans. 2008, 36:491.
106. Scheu S., Stetson D.B., Reinhardt R.L., Leber J.H., Mohrs M., Locksley R.M. Activation of the integrated stress response during T helper cell differentiation. Nat. Immunol. 2006, 7:644.
107. Schichl Y.M., Resch U., Hofer-Warbinek R., de Martin R. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J. Biol. Chem. 2009, 284:29571.
108. Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M., Gross B., Gherzi R., Hess D., Hemmings B.A., Moroni C. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J. 2004, 23:4760.
109. Schmidt-Supprian M., Rajewsky K. Vagaries of conditional gene targeting. Nat. Immunol. 2007, 8:665.
110. Schwanhausser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337.
111. Seko Y., Azmi H., Fariss R., Ragheb J.A. Selective cytoplasmic translocation of HuR and site-specific binding to the interleukin-2 mRNA are not sufficient for CD28-mediated stabilization of the mRNA. J. Biol. Chem. 2004, 279:33359.
112. Sherman M.H., Kuraishy A.I., Deshpande C., Hong J.S., Cacalano N.A., Gatti R.A., Manis J.P., Damore M.A., Pellegrini M., Teitell M.A. AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. Mol. Cell 2010, 39:873.
113. Shim J., Lim H.R., Yates J., Karin M. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol. Cell 2002, 10:1331.
114. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., Blackshear P.J., Anderson P. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 2008, 283:11689.
115. Stellato C., Gubin M.M., Magee J.D., Fang X., Fan J., Tartar D.M., Chen J., Dahm G.M., Calaluce R., Mori F., Jackson G.A., Casolaro V., et al. Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J. Immunol. 2011, 187:441.
116. Stumpo D.J., Byrd N.A., Phillips R.S., Ghosh S., Maronpot R.R., Castranio T., Meyers E.N., Mishina Y., Blackshear P.J. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol. Cell. Biol. 2004, 24:6445.
117. Stumpo D.J., Broxmeyer H.E., Ward T., Cooper S., Hangoc G., Chung Y.J., Shelley W.C., Richfield E.K., Ray M.K., Yoder M.C., Aplan P.D., Blackshear P.J. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 2009, 114:2401.
118. Sultan M., Schulz M.H., Richard H., Magen A., Klingenhoff A., Scherf M., Seifert M., Borodina T., Soldatov A., Parkhomchuk D., Schmidt D., O'Keeffe S., et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321:956.
119. Sun L., Stoecklin G., Van Way S., Hinkovska-Galcheva V., Guo R.F., Anderson P., Shanley T.P. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J. Biol. Chem. 2007, 282:3766.
120. Sun D., Novotny M., Bulek K., Liu C., Li X., Hamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 2011, 12:853.
121. Swanson B.J., Murakami M., Mitchell T.C., Kappler J., Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 2002, 17:605.
122. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., Blackshear P.J. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445.
123. Tiedje C., Kotlyarov A., Gaestel M. Molecular mechanisms of phosphorylation-regulated TTP (tristetraprolin) action and screening for further TTP-interacting proteins. Biochem. Soc. Trans. 2010, 38:1632.
124. Tudor C., Marchese F.P., Hitti E., Aubareda A., Rawlinson L., Gaestel M., Blackshear P.J., Clark A.R., Saklatvala J., Dean J.L. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett. 2009, 583:1933.
125. Uren P.J., Burns S.C., Ruan J., Singh K.K., Smith A.D., Penalva L.O. Genomic analyses of the RNA-binding protein Hu antigen R (HuR) identify a complex network of target genes and novel characteristics of its binding sites. J. Biol. Chem. 2011, 286:37063.
126. Vavassori S., Shi Y., Chen C.C., Ron Y., Covey L.R. In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur. J. Immunol. 2009, 39:2224.
127. Villarino A.V., Katzman S.D., Gallo E., Miller O., Jiang S., McManus M.T., Abbas A.K. Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 2011, 34:50.
128. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., Roberts I.S., Copley R.R., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435:452.
129. Vlasova I.A., McNabb J., Raghavan A., Reilly C., Williams D.A., Bohjanen K.A., Bohjanen P.R. Coordinate stabilization of growth-regulatory transcripts in T cell malignancies. Genomics 2005, 86:159.
130. Vlasova I.A., Tahoe N.M., Fan D., Larsson O., Rattenbacher B., Sternjohn J.R., Vasdewani J., Karypis G., Reilly C.S., Bitterman P.B., Bohjanen P.R. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol. Cell 2008, 29:263.
131. von Boehmer H., Fehling H.J. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 1997, 15:433.
132. Walzer T., Marcais A., Saltel F., Bella C., Jurdic P., Marvel J. Cutting edge: Immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J. Immunol. 2003, 170:1615.
133. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470.
134. Weng A.P., Ferrando A.A., Lee W., Morris J.P., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269.
135. Wu Z., Jia X., de la Cruz L., Su X.C., Marzolf B., Troisch P., Zak D., Hamilton A., Whittle B., Yu D., Sheahan D., Bertram E., et al. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity 2008, 29:863.
136. Yamamoto H., Tsukahara K., Kanaoka Y., Jinno S., Okayama H. Isolation of a mammalian homologue of a fission yeast differentiation regulator. Mol. Cell. Biol. 1999, 19:3829.
137. Yarovinsky T.O., Butler N.S., Monick M.M., Hunninghake G.W. Early exposure to IL-4 stabilizes IL-4 mRNA in CD4+ T cells via RNA-binding protein HuR. J. Immunol. 2006, 177:4426.
138. Yiakouvaki A., Dimitriou M., Karakasiliotis I., Eftychi C., Theocharis S., Kontoyiannis D.L. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J. Clin. Invest. 2012, 122:48.
139. Yu D., Tan A.H., Hu X., Athanasopoulos V., Simpson N., Silva D.G., Hutloff A., Giles K.M., Leedman P.J., Lam K.P., Goodnow C.C., Vinuesa C.G. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007, 450:299.
140. Zhang L., Lee J.E., Wilusz J., Wilusz C.J. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: Implications for myotonic dystrophy. J. Biol. Chem. 2008, 283:22457.
141. Zou T., Liu L., Rao J.N., Marasa B.S., Chen J., Xiao L., Zhou H., Gorospe M., Wang J.Y. Polyamines modulate the subcellular localization of RNA-binding protein HuR through AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1. Biochem. J. 2008, 409:389.